To the Editor.—
Most of the comments concerning immunoblastic lymphadenopathy (236:2098, 1976) are quite appropriate. However, I would like to emphasize the original authorship of this entity. It is stated that Frizzera et al1 are the "first authors to give sufficient emphasis to the importance" of this disorder. The article by Lukes and Tindle2 followed six months after that by Fizzera et al, who note in their introduction that this lesion was described by Lukes at a workshop on classification of non-Hodgkin's lymphomas held from June 25 to June 29, 1973. Lukes and Tindle were the first to describe immunoblastic lymphadenopathy at this and similar meetings3 after they recognized that this lesion was a histopathologic entity that must be distinguished from malignant lymphomas and Hodgkin's disease. Therefore, they should be given proper recognition, as Frizzera and coworkers do in their second reference.Furthermore, Lukes' larger series was collected over
Glassy FJ. Immunoblastic Lymphadenopathy. JAMA. 1977;237(26):2811–2812. doi:10.1001/jama.1977.03270530019004
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: